dissecting genomic complexity underlying medulloblastoma 
medulloblastoma aggressively growing tumour arising cerebellum medulla/brain stem common malignant brain tumour children shows tremendous biological clinical heterogeneity despite recent treatment advances approximately % children experience tumour recurrence % will die disease survive often significantly reduced quality life four tumour subgroups distinct clinical biological genetic profiles currently identified wnt tumours showing activated wingless pathway signalling carry favourable prognosis current treatment regimens shh tumours show hedgehog pathway activation intermediate prognosis group tumours molecularly less well characterized also present greatest clinical challenges full repertoire genetic events driving distinction however remains unclear describe integrative deep-sequencing analysis tumour-normal pairs conducted part international cancer genome consortium icgc pedbrain tumor project tetraploidy identified frequent early event group tumours positive correlation patient age mutation rate observed several recurrent mutations identified known medulloblastoma-related genes ctnnb1 ptch1 mll2 smarca4 genes previously linked tumour ddx3x ctdnep1 kdm6a tbr1 often subgroup-specific patterns rna sequencing confirmed alterations revealed expression knowledge first medulloblastoma fusion genes identified chromatin modifiers frequently altered across subgroups findings enhance understanding genomic complexity heterogeneity underlying medulloblastoma provide several potential targets new therapeutics especially group patients 
